Exploring Structural Requirements for Sigma-1 Receptor Linear Ligands: Experimental and Computational Approaches

Area of Science:

• Pharmacology and Computational Chemistry
• Neuroscience and Drug Discovery

Background:

• The sigma-1 receptor (S1R) is a key protein involved in numerous biological functions, interacting with various proteins and ion channels.
• Understanding S1R's structure, particularly its trimeric organization and ligand-binding pocket, is crucial for developing targeted therapeutics.

Purpose of the Study:

• To develop a highly selective and accurate pharmacophore model for the sigma-1 receptor (S1R).
• To utilize computational simulations and experimental validation to guide the discovery of novel S1R ligands.

Main Methods:

• Applied a multistep computational procedure, including molecular dynamics simulations of S1R cocrystal structures.
• Developed a pharmacophore model incorporating specific hydrophobic features and excluded volumes for enhanced selectivity.
• Validated the model using ROC curve analysis and experimentally tested new 4-phenylpiperazine-based compounds via synthesis and binding assays.

Main Results:

• The developed pharmacophore model accurately identified key features, including positive ionizable, hydrophobic features, and specific excluded volumes.
• The model demonstrated high predictive power in distinguishing active from inactive S1R ligands.
• A novel synthesized compound, 2-(3-methyl-1-piperidyl)-1-(4-phenylpiperazin-1-yl)ethanone (3), exhibited S1R affinity comparable to haloperidol (Ki values of 4.8 nM vs. 2.6 nM).

Conclusions:

• The refined pharmacophore model serves as a valuable tool for the rational design and discovery of potent sigma-1 receptor ligands.
• This study highlights the successful integration of computational modeling and experimental validation in drug discovery for S1R.